Toronto, ON – TheNewswire - April 23, 2021 - conversationHEALTH, the conversational AI platform purpose-built for the Life Sciences industry has announced it is scaling growth across all divisions of the organization in North America, Europe, and Asia-Pacific. This includes the hiring of Chery Burt, VP, Strategy to lead thought leadership and go-to-market planning with customers and partners, and Kei Kubo, Managing Director of APAC, to lead business development and build strategic partnerships across the Asia-Pacific market.

Click Image To View Full Size

“I am delighted to welcome Chery Burt, Kei Kubo and all the new hires to the conversationHEALTH team.  As we continue to expand our Life Sciences customer base globally, their multifaceted background in healthcare and strategic business acumen, is the perfect match for our company” states Richard Marcil, Chief Customer Officer of conversationHEALTH.

Cheryl Burt is a marketing and strategy veteran with 20 years experience in the health and wellness sector. She has held local and regional marketing roles as well as global strategy roles in her career, including senior product roles at Johnson & Johnson. Most recently, Cheryl was VP of Marketing, Innovation and Digital Strategy at Bayer Consumer Health Canada.

“I am very excited to join conversationHEALTH at what feels like an inflection point in the Life Sciences industry.  I look forward to collaborating with Pharma, Biotech and Medical Devices teams to reimagine and reinvent how they engage with their customers and patients in an impactful and scalable way for true value creation” notes Burt.

Kei Kubo has held a number of senior leadership roles in international business development and marketing. After working as a corporate strategist at Dentsu in Japan, he transferred to the Canadian Branch as Vice President of International Development, successfully leading the global expansion of several top tier clients in the IoT, manufacturing and consumer goods industry. Kei has also worked as an Investment Advisor of JETRO Canada, Japanese External Trade Organization, providing support to start-up and venture companies, particularly in AI and other high-tech industries within Canada.

“In my role as Managing Director, APAC, I am looking forward to bringing conversational AI solutions to the Life Sciences industry in the Asia-Pacific market, and strongly believe we have the ability to change the way this industry does business as they deploy AI agents for customers and patients to easily access medical and product information - when and where they need it” states Kubo.

As Life Sciences companies continue to expand digital engagement with employees, customers, and patients, conversationHEALTH is deploying sophisticated AI agents that work hand-in-hand with them for 24/7/365 support of medical information, education and service, all for better health outcomes.

To learn more about conversationHEALTH’s conversational AI solutions for the Life Sciences industry, visit: conversationhealth.com

About conversationHEALTH:

conversationHEALTH is a group of life sciences experts, artificial intelligence engineers, software developers, data scientists and conversational architects that, together, are building industry-changing conversational AI solutions.  The conversationHEALTH SaaS platform is purpose-built for the life sciences industry, and sets the standard in terms of accuracy and compliance with medically-trained taxonomies, data sets, NLP and technical stack.  The platform also integrates with all major software providers in the life sciences industry, who are deploying conversational agents in clinical trials, medical affairs and commercial lines of business.

conversationHEALTH is based in Toronto, Canada with offices in North America and in Europe. For more information, visit conversationhealth.com

For media inquiries contact:
Jessica Naman

Director of Marketing

jessica@conversationhealth.com